Whitehawk Therapeutics (WHWK) Receivables - Net (2016 - 2024)

Whitehawk Therapeutics (WHWK) has 6 years of Receivables - Net data on file, last reported at $5.9 million in Q4 2024.

• On a quarterly basis, Receivables - Net rose 7.56% year-over-year to $5.9 million in Q4 2024; TTM through Dec 2024 was $5.9 million, a 7.56% increase from a year earlier, with the FY2024 full-year figure at $5.9 million, up 7.56% from the prior year.
• Receivables - Net for Q4 2024 stood at $5.9 million, down from $6.5 million in the prior quarter.
• Over the last five years, Receivables - Net for WHWK reached as high as $14.1 million in Q4 2020 and fell as low as $1.9 million in Q4 2022.
• Historically, Receivables - Net has averaged $5.1 million across 4 years, with a median of $5.5 million in 2023.
• Across the five-year window, Receivables - Net jumped 194.74% in 2023 and dropped 11.36% in 2024, its largest moves.
• Year by year, Receivables - Net stood at $14.1 million in 2020, then sank by 86.84% to $1.9 million in 2022, then soared by 194.74% to $5.5 million in 2023, then grew by 7.56% to $5.9 million in 2024.
• Per Business Quant data, the three most recent Receivables - Net figures were $5.9 million in Q4 2024, $6.5 million in Q3 2024, and $5.9 million in Q2 2024.